Aurobindo Pharma has received Canadian regulatory authority's approval for Unit III for oral solid dosage forms and Unit VI for sterile and non-sterile cephalosporin dosage forms. Health Canada has approved the aforementioned sites.According to a release issued by Aurobindo Pharma to the BSE, the company's Unit III at Hyderabad has four production blocks and is dedicated to products other than cephalosporins / penicillin's oral dosage formulations. In addition, it holds ISO and approvals from several other countries.The release further stated that Unit VI oral dosage formulations is also approved by US FDA, MCC- South Africa, Brazilian ANVISA and many other regulatory agencies apart from Canadian authority, and is located near Hyderabad, Andhra Pradesh.
